Investigation of the Keloid treatment results using plasma device combined with or without triamcinolone injectio
Phase 3
- Conditions
- Keloid.Other specified disorders of skin and subcutaneous tissue in diseases classified elsewhereL99.8
- Registration Number
- IRCT20230801058997N1
- Lead Sponsor
- Islamic Azad University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 20
Inclusion Criteria
The minimum age is 18 and the maximum age is 70 years
Informed consent to participate in the study
People who have the possibility of follow-up after treatment
People who have a keloid scar with a maximum height of 5 mm
Exclusion Criteria
Pregnant or lactating patients and children under 15 years old due to the possible side effects of triamcinolone
People who have had a history of treatment at the site of the lesion in the last 6 months
People who have any type of underlying disease that affects wound healing
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method